Close
×
Subscribe Now
By entering these details you are signing up to receive our newsletter.
First Name
Last Name
Your Email
Type of visitor?
Individuals with a rare condition
Caregiver/family member
Industry/biotech/pharma
Healthcare professionals
Charity/advocate
General interest
Newsletters
RAREBite Newsletter Subscribers (Twice Weekly)
Magazine and RARE Round-Up Weekly Newsletter
Latest Edition
RARE lysosomal
Subscribe Now
Home
Meet the team
Magazine
RARE INSIGHTS
A day in the life
Charity & advocacy
Industry insights
Letters
Medical
News
Patient voice
RARE caregiving
RARE ramblings
RARE REV-inar
Reviews
Science & tech
Sunday sessions
Turning the tide for rare disease
THE PEOPLE OF RARE
Digital Spotlight
RARE Reports
RARE Siblings
Resources
Charity Partners
WORK WITH US
Rare Revolutionaries
Community Gallery
Rare Youth
SHOP
Latest Edition
RARE lysosomal
Subscribe Now
To use more accessibility options, please use a different browser such as Chrome or Firefox.
Rare insights
Rare insights
ARRE Foundation awards new research grant focused on ASXL3 disease mechanisms and future therapeutic development
By admin
22 May 2026
Rare insights
CureDuchenne appoints Lidia Gardner, PhD, EMBA, as vice president of clinical and medical affairs to advance patient-centered care, research, and strategic partnerships
By admin
22 May 2026
Rare insights
Fighting for life and hope
By CONTRIBUTOR
20 May 2026
Rare insights
The science of hope: a father’s race against the irreversible
By CONTRIBUTOR
13 May 2026
Rare insights
Listening to lead: how rare disease communities guide innovation
By CONTRIBUTOR
13 May 2026
Rare insights
Global nonprofit CureDuchenne to host FUTURES National Conference for the Duchenne and Becker muscular dystrophy community
By admin
5 May 2026
Rare insights
Navigating the future: iDR26, the 2026 International Drug Repurposing Conference
By admin
5 May 2026
Rare insights
From a moment, to momentum: Why Undiagnosed Day 2026 is shaping what happens next
By CONTRIBUTOR
29 April 2026
Rare insights
The power of your participation: strengthening data robustness and ethical trial design with natural history data
By CONTRIBUTOR
27 April 2026
Rare insights
Novartis receives EMA CHMP positive opinion for Itvisma, gene therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
By admin
24 April 2026
Rare insights
The student-led revolution in medical genetics
By CONTRIBUTOR
24 April 2026
Rare insights
Expediting novel therapies: a roadmap to a bright future for Saudi Arabia’s citizens
By Emma Bishop, RARE Revolution
22 April 2026
Rare insights
The invisible battle: how MSA rewrote my soul
By CONTRIBUTOR
19 April 2026
Rare insights
Rare but strong: turning a diagnosis into a community
By CONTRIBUTOR
18 April 2026
Rare insights
Research shows eye movement tests can help clinicians spot PSP earlier
By admin
17 April 2026
Rare insights
The diagnostic odyssey: how misdiagnosis and indication broadening can undermine rare disease clinical trials
By CONTRIBUTOR
8 April 2026
Rare insights
When strength looks like rest
By CONTRIBUTOR
8 April 2026
1
2
3
…
46
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset